tiprankstipranks
Trending News
More News >
Genscript Biotech (HK:1548)
:1548
Hong Kong Market

Genscript Biotech (1548) Income Statement

Compare
5 Followers

Genscript Biotech Income Statement

Last quarter (Q2 2024), Genscript Biotech's total revenue was $561.37M, an increase of 81.33% from the same quarter last year. In Q2, Genscript Biotech's net income was $-175.12M. See Genscript Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 594.49M$ 839.53M$ 625.70M$ 490.10M$ 390.85M
Gross Profit
$ 272.13M$ 409.55M$ 304.08M$ 282.52M$ 255.89M
Operating Expenses
$ 262.84M$ 409.55M$ 735.72M$ 804.05M$ 544.38M
Depreciation and Amortization
$ 61.15M$ 74.05M$ 64.25M$ 47.78M$ 32.90M
EBITDA
$ 70.43M$ -249.42M$ -389.04M$ -341.57M$ -174.71M
Operating Income
$ 9.28M$ -415.79M$ -438.11M$ -379.29M$ -204.55M
Other Income/Expenses
$ -180.08M$ 64.81M$ -3.93M$ -138.07M$ -77.35M
Pretax Income
$ -170.80M$ -350.98M$ -431.69M$ -517.36M$ -281.90M
Net Income
$ 2.96B$ -95.48M$ -226.85M$ -358.71M$ -204.94M
Per Share Metrics
Basic EPS
$ 0.00$ -0.05$ -0.11$ -0.18$ -0.11
Diluted EPS
$ -0.03$ -0.05$ -0.11$ -0.18$ -0.11
Weighted Average Shares Outstanding
93.52B 2.11B 2.10B 2.03B 1.90B
Weighted Average Shares Outstanding (Diluted)
2.18B 2.11B 2.10B 2.03B 1.90B
Currency in USD

Genscript Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis